P2Y12 receptor specific versus non-P2Y12 receptor specific platelet function testing for prediction of pharmacodynamic and clinical outcomes in patients on dual antiplatelet therapy

被引:0
|
作者
Amann, M. [1 ]
Valina, C. [1 ]
Stratz, C. [1 ]
Boemicke, T. [1 ]
Kleiner, P. [1 ]
Trenk, D. [1 ]
Neumann, F. -J. [1 ]
Hochholzer, W. [1 ]
机构
[1] Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol 2, Bad Krozingen, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P5605
引用
收藏
页码:1163 / 1163
页数:1
相关论文
共 50 条
  • [21] Ligand recognition by the human platelet P2Y12 receptor
    von Kuegelgen, Ivar
    Algaier, Irina
    Hoffmann, Kristina
    PURINERGIC SIGNALLING, 2010, 6 (01) : 61 - 61
  • [22] Central role of the P2Y12 receptor in platelet activation
    Dorsam, RT
    Kunapuli, SP
    JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (03): : 340 - 345
  • [23] Molecular mechanisms of platelet P2Y12 receptor regulation
    Cunningham, Margaret R.
    Nisar, Shaista P.
    Mundell, Stuart J.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 : 225 - 230
  • [24] Progress in Platelet Blockers: The Target is the P2Y12 Receptor
    Patel, Prakash A.
    Lane, Bernard
    Augoustides, John G. T.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2013, 27 (03) : 620 - 624
  • [25] Platelet P2Y12 Receptor InhibitionAn Update on Clinical Drug Development
    David Vivas
    Dominick J. Angiolillo
    American Journal of Cardiovascular Drugs, 2010, 10 : 217 - 226
  • [26] Platelet P2Y12 Receptor Inhibition An Update on Clinical Drug Development
    Vivas, David
    Angiolillo, Dominick J.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (04) : 217 - 226
  • [27] Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing
    Aradi, Daniel
    Tornyos, Adrienn
    Pinter, Tuende
    Vorobcsuk, Andras
    Konyi, Attila
    Falukoezy, Jozsef
    Veress, Gabor
    Magyari, Balazs
    Horvath, Ivan G.
    Komocsi, Andras
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (11) : 1061 - 1070
  • [28] Advances in antiplatelet therapy: overview of new P2Y12 receptor antagonists in development
    Cattaneo, Marco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2008, 10 (0I) : 33 - 37
  • [29] CORRELATION BETWEEN THE VERIFYNOW P2Y12 ASSAY AND LIGHT TRANSMITTANCE AGGREGOMETRY TO MEASURE PLATELET P2Y12 RECEPTOR INHIBITION IN PATIENTS ON CLOPIDOGREL THERAPY
    Ueno, Masafumi
    Ferreiro, Jose Luis
    Dharmashankar, Kodlipet
    Capranzano, Piera
    Capodanno, Davide
    Darlington, Andrew
    Bhaloo, Desai
    Charlton, Ronald
    Box, Lyndon
    Zenni, Martin
    Guzman, Luis
    Bass, Theodore
    Angiolillo, Dominick J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [30] The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor
    Bouman, Heleen J.
    van Werkum, Jochem W.
    Rudez, Goran
    Leebeek, Frank W. G.
    Kruit, Adrian
    Hackeng, Christian M.
    ten Berg, Jurrien M.
    de Maat, Moniek P. M.
    Ruven, Henk J. T.
    THROMBOSIS AND HAEMOSTASIS, 2010, 103 (02) : 379 - 386